期刊文献+

一例17α-羟化酶/17,20-碳链裂解酶缺陷症患儿的CYP17A1基因突变分析 被引量:5

Analysis of CYP17A1 gene mutation in a child patient with 17α-hydroxylase/17,20-1yase deficiency
原文传递
导出
摘要 目的对1例17α-羟化酶/17,20-碳链裂解酶缺陷症( 17α-hydroxylase/17, 20-1yase deficiency, 17OHD)的患儿进行CYPI7A1基因突变分析,同时分析中国170HD患者的CYPI7A1基因突变特点。方法收集患者的临床资料,应用PCR和DNA测序技术对患者进行CYP17A1基因的突变检测。结果患者临床表现较典型:高血压、低血钾、性激素和皮质醇明显低于正常、促肾上腺皮质激素升高。患者的CYP17A1基因第6外显子上发现c.987C〉A(p.Y329X)以及c.985del(P.Y329TfsX89)复合杂合突变,分别生成包含328和417个氨基酸的截短蛋白。结论在患者的CYP17A1基因上发现了c.985del和c.987C〉A复合杂合突变。我国患者中最常见类型为错义突变,且集中于第6和第8外显子。 Objective To analyze CYP17A1 gene mutations in a child patient with 17a-hydroxylase/ 17,20-1yase deficiency (17OHD), and to review characteristics of CYP17A1 gene mutations in Chinese patients with 17OHD. Methods Clinical data were collected. PCR and DNA sequencing were performed to detect mutations in the patient. Results The patient has presented classical features of 17OHD including hypertension, hypokalemia, decreased sex hormones and plasma cortisol, and elevated blood adrenocorticotrophic hormone. A compound heterozygous mutation c. 987C〉A and c. 985del was detected in the CYP17A1 gene, which resulted in two premature stop eodons at positions 328 and 417. Conclusion A compound mutation, c. 987C〉A and c. 985del, has been identified in a patient with 17OHD. Among CYP17A1 gene mutations identified in Chinese patients, missence mutations have been most common, and exons 5 and 8 have been the mutation hotspots.
出处 《中华医学遗传学杂志》 CAS CSCD 北大核心 2013年第4期439-442,共4页 Chinese Journal of Medical Genetics
基金 国家自然科学基金(81170581)
关键词 17Α-羟化酶 17 20-碳链裂解酶缺陷症 CYP17A1基因 突变 17α-hydroxylase/17,20-lyase deficiency CYPI7A1 gene Mutation
  • 相关文献

参考文献23

二级参考文献130

共引文献69

同被引文献21

  • 1郑瑞芝,虎子颖,杨俊朋,张云,汪艳芳,袁倩,李家大.五例17α-羟化酶缺陷症患者的CYP17A1基因突变分析[J].中华医学遗传学杂志,2019,36(9):877-881. 被引量:3
  • 2杨军,李小英,孙首悦,乔洁,赵咏桔,刘建民,宁光,许曼音,陈家伦.10例17α羟化酶/17,20碳链裂解酶缺陷症临床和遗传学研究[J].上海交通大学学报(医学版),2006,26(1):17-21. 被引量:22
  • 3陶红,陆召麟,张波,米树华,王南晔,王曦之,吴尽.中国人17α-羟化酶/17 ,20-裂解酶缺乏症基因突变研究(英文)[J].中华医学遗传学杂志,2006,23(2):125-128. 被引量:13
  • 4杨明辉,吴新宝,李庭,王满宜.17α-羟化酶缺陷症临床及分子遗传学研究[J].中华医学杂志,2006,86(41):2900-2904. 被引量:12
  • 5YANASE T, SIMPSON E R, WATERMAN M R. 17 alpha-hydroxylase/17, 20-1yase deficiency from clinical investigation to molecular definition[J]. Endocr Rev, 1991, 12(1) .. 91-108.
  • 6BIGLIERI E G, HERRON M A, BRUST N. tT- hydroxylation deficiency in man[J]. J Clin Invest, 1966, 45 (12): 1946-1954.
  • 7陈家伦,许曼音,张达青.等.17-羟化酶缺陷症一附一例报道[J].上海第二医学院学报,1982,(4):109-112.
  • 8ZHANG M, SUN S, LIU Y, et al. New, recurrent, and prevalent mutations Clinical and molecular characterization of 26 Chinese patients with 17alpha-hydroxylase/17, 20- lyase defieieney[J]. J Steroid Biochem Mol Biol, 2015, 150.. 11-16.
  • 9YAO F, HUANG S, KANG X, et al. CYP17A1 mutations identified in 17 Chinese patients with 17a-hydroxylase/17, 20-1yase deficiency[J]. Gynecol Endocrinol, 2013, 29 (1) 10-15.
  • 10MIURA K, YASUDA K, YANASE T, et al. Mutation of cytochrome P-45017 alpha gene (CYP17) in a Japanese patient previously reported as having glucoeorticoid- responsive hyperaldosteronism with a review of Japanese patients with mutations of CYP17 [J]. J Clin Endocrinol Metab, 1996, 81(10).. 3797-3801.

引证文献5

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部